Protocol for the phase 2 EDELIFE trial investigating the efficacy and safety of intra-amniotic ER004 administration to male subjects with X-linked hypohidrotic ectodermal dysplasia

Authors

Holm Schneider, Friedrich-Alexander University Erlangen-Nürnberg
Smail Hadj-Rabia, University of Paris-Cité
Florian Faschingbauer, University Hospital Erlangen
Christine Bodemer, University of Paris-Cité
Dorothy K Grange, Washington University School of Medicine in St. Louis
Mary E Norton, University of California, San Francisco
Riccardo Cavalli, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Gianluca Tadini, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Holger Stepan, University Hospital Leipzig
Angus Clarke, Cardiff University
Encarna Guillén-Navarro, University of Murcia
Sigrun Maier-Wohlfart, Friedrich-Alexander University Erlangen-Nürnberg
Athmane Bouroubi, Pierre Fabre Médicament
Florence Porte, EspeRare Foundation

Journal

Genes

Publication Date

1-6-2023

Volume

14

Issue

1

First Page

153

Document Type

Open Access Publication

DOI

10.3390/genes14010153

Rights and Permissions

Schneider, H.; Hadj-Rabia, S.; Faschingbauer, F.; Bodemer, C.; Grange, D.K.; Norton, M.E.; Cavalli, R.; Tadini, G.; Stepan, H.; Clarke, A.; Guillén-Navarro, E.; Maier-Wohlfart, S.; Bouroubi, A.; Porte, F. Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia. Genes 2023, 14, 153. https://doi.org/10.3390/genes14010153 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Schneider, Holm; Hadj-Rabia, Smail; Faschingbauer, Florian; Bodemer, Christine; Grange, Dorothy K; Norton, Mary E; Cavalli, Riccardo; Tadini, Gianluca; Stepan, Holger; Clarke, Angus; Guillén-Navarro, Encarna; Maier-Wohlfart, Sigrun; Bouroubi, Athmane; and Porte, Florence, "Protocol for the phase 2 EDELIFE trial investigating the efficacy and safety of intra-amniotic ER004 administration to male subjects with X-linked hypohidrotic ectodermal dysplasia." Genes. 14, 1. 153 (2023).
https://digitalcommons.wustl.edu/oa_4/1154